Work

Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: A collaborative Children's Oncology Group/National Cancer Institute pilot trial (CCG‐1942)

Year: 2006

Type: article

Study design: Clinical Trial

Source: Pediatric Blood & Cancer

DOI: 10.1002/pbc.20964

Authors: Shana S. Jacobs, Linda C. Stork, Bruce C. Bostrom, Ray Hutchinson, John Holcenberg, Gregory H. Reaman, Gary Erdmann, Janet Franklin, Joseph P. Neglia, Seth M. Steinberg, Frank M. Balis, Peter C. Adamson

Institutions: National Institutes of Health, Children's National, National Cancer Institute, Oregon Health & Science University, Children's Minnesota, C. S. Mott Children's Hospital, Seattle Children's Hospital, Children's Oncology Group, Children's Hospital Los Angeles, University of Minnesota, Masonic Cancer Center, Center for Cancer Research

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Arcadia Fund, National Institutes of Health, National Cancer Institute, National Center for Research Resources

Awards: G236944051, G278975345, G301932103, CHILDRENS CANCER GROUP CHAIRMANS AWARD, General Clinical Research Center, Children's Oncology Group Chair's Grant

OpenAlex ID: W2147900187

FWCI: 2.486

Cites: 36

Cited by: 27

Related to: 10